Terlipressin

Is Terlipressin legal in the US?

Yes, FDA approved for kidney failure from liver disease (hepatorenal syndrome).

Terlipressin is approved by the FDA as Terlivaz (September 2022) to improve kidney function in adults with hepatorenal syndrome with rapid reduction in kidney function. The label carries a boxed warning for serious or fatal respiratory failure. ²

Yes. Terlivaz was approved in September 2022. Its approved use is to improve kidney function in adults with hepatorenal syndrome with rapid reduction in kidney function. Europe and other places had used it for many years before that. ²

Read the full Terlipressin page

Reference information only, not medical advice. Drawn from the Terlipressin article, fact-checked against the cited sources. No dosing anywhere on this site.